Transplant International

, Volume 4, Issue 4, pp 227–230 | Cite as

The intra-operative use of trasylol (aprotinin) in liver transplantation

  • S. V. Mallett
  • D. Cox
  • A. K. Burroughs
  • K. Rolles
Original Articles


Aprotinin has been reported to reduce blood loss in difficult cases requiring cardiopulmonary bypass surgery and more recently in liver transplantation. Over a 9-month period were compared the effects of an intra-operative infusion of aprotinin on transfusion requirements and coagulation profiles in 12 patients undergoing liver transplantation for end-stage cirrhosis with an equal number of consecutive transplants in patients with similar pathology who did not receive aprotinin. Transfusion of blood and blood products was reduced to one-third in the aprotinin-treated group. Operative time was also significantly reduced, as was ICU stay post-operatively. Aprotinin profoundly inhibits fibrinolysis and this is likely to be the major effect by which blood loss is reduced. Thromboelastography revealed severe fibrinolytic changes in the anhepatic stage in 4 of 6 controlled patients; this accelerated in 3 following reperfusion of the new graft. By contrast, only 1 patient of 12 in the aprotinin-treated group showed fibrinolytic activity in the anhepatic period, and none showed evidence of fibrinolysis following reperfusion of the new graft.

Key words

Liver transplantation, trasylol Trasylol, liver transplantation Aprotinin, liver transplantation 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Fletcher AP, Biederman O, Moore D, Alkjaersig N, Sherry S (1964) Abnormal plasminogen-plasmin system activity (fibrinolysis) in patients with hepatic cirrhosis. J Clin Invest 43: 681–695Google Scholar
  2. 2.
    Hunt BJ, Cottam S, Segal H, Ginsburg R, Potter D (1990) Inhibition by Aprotinin of tPA — mediated fibrinolysis during orthotopic liver transplantation Lancet I: 336–381Google Scholar
  3. 3.
    Kang Y, Lewis JH, Navalgund A, Russell MW, Bontempo FA, Niren LS, Starzl TE (1987) Epsilon-aminocaproic acid for treatment of fibrinolysis during liver transplantation. Anesthesiology 66: 766–773Google Scholar
  4. 4.
    Neuhaus P, Bechstein WO, Lefebre O, Blumhardt G, Slama K (1989) Effect of Aprotinin on intraoperative bleeding and fibrinolysis in liver transplantation. Lancet II: 924–925Google Scholar
  5. 5.
    Porte RJ, Bontempo FA, Knott EAR (1989) Systemic effects of tissue plasminogen activator associated fibrinolysis and its relation to thrombin generation in orthotopic liver transplantation. Transplantation 47: 978–984Google Scholar
  6. 6.
    Royston D, Taylor KM, Bidstrup BP, Sapsford RN (1987) Effect of Aprotinin on the need for blood transfusions after repeat open heart surgery. Lancet I: 1289–1291Google Scholar
  7. 7.
    Tice DA, Worth MH, Clauss RH, Reed GH (1964) The inhibition by Trasylol of fibrinolytic activity associated with cardiovascular operations. Surg Gynecol Obstet 119: 71–74Google Scholar

Copyright information

© Springer-Verlag 1991

Authors and Affiliations

  • S. V. Mallett
    • 1
  • D. Cox
    • 1
  • A. K. Burroughs
    • 2
  • K. Rolles
    • 3
  1. 1.Department of AnaesthesiaThe Royal Free Hospital and School of MedicineLondonUK
  2. 2.Department of MedicineThe Royal Free Hospital and School of MedicineLondonUK
  3. 3.Department of SurgeryThe Royal Free Hospital and School of MedicineLondonUK

Personalised recommendations